Public Company News
Pop Culture Group Co., Ltd Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
XIAMEN, China, March 21, 2025 /PRNewswire/ -- Pop Culture Group Co., Ltd ("Pop Culture" or the "Company") (Nasdaq: CPOP), a hip-hop culture company headquartered inChina, today announced that the Company received a notification letter (the "Notification Letter") from the Listing Qualifications De...
Harbour BioMed Enters into Global Strategic Collaboration with AstraZeneca to Discover and Develop Next-Generation Therapeutic Antibodies
SHANGHAI, CAMBRIDGE, Mass. and ROTTERDAM, Netherlands, March 21, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics in immunology and oncology, today announced a global ...
51Talk Online Education Group Announces the Results for the Fourth Quarter and Full Year 2024
SINGAPORE, March 21, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced its unaudited results for the fourth quarter and full year endedDecember 31, 2024. Full...
China Yuchai Subsidiary Adopts Equity Incentive Plan
SINGAPORE, March 21, 2025 /PRNewswire/ -- China Yuchai International Limited (NYSE: CYD)("China Yuchai" or the "Company") one of the largest powertrain solution manufacturers through its main operating subsidiary inChina, Guangxi Yuchai Machinery Company Limited ("Yuchai"), today announced an equ...
Akeso's Cadonilimab Combined with Concurrent Chemoradiotherapy Demonstrates Promising Efficacy in Locally Advanced Cervical Cancer: Data Published at the 2025 SGO Annual Meeting
HONG KONG, March 20, 2025 /PRNewswire/ -- Akeso Inc. (9926.HK) presented promising phase III safety run-in results from the COMPASSION-18/AK104-305 study, at the 2025 Annual Meeting of the Society of Gynecologic Oncology (SGO). The study evaluates the global first-in-class PD-1/CTLA-4 bispecific ...
BUMA Completes Inaugural Sukuk Issuance, the Largest A+ Sharia-Rated Corporate Sukuk Ijarah in a Single Issuance in Indonesia[1]
* BUMA has successfully completed the issuance of its inaugural Sukuk Ijarah I BUMA 2025, with a total value ofRp2 trillion, making it the Largest A+ Sharia-rated corporate Sukuk Ijarah in a single issuance inIndonesia[2]. * The Sukuk was oversubscribed by 1.1x, reflecting strong investor dema...
WuXi Biologics Named to CDP Water Security "A List" for Second Consecutive Year
* Launching the Water Excellence Stewardship (WES) program to advance UN Sustainable Development Goal 6 (SDG6) * Contributing to the 2025 World Water Day campaign to ensure the availability of water and sanitation for all SHANGHAI, March 20, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2...
Noul Showcases AI-Powered Cervical Cancer Cell Screening Technology at NVIDIA GTC 2025
* Company Joins NVIDIA Healthcare & Life Sciences (HCLS) Ecosystem to Advance Global Diagnostic Accessibility and Seeks Partnerships with Global Healthcare Opportunities YONGIN, South Korea, March 20, 2025 /PRNewswire/ -- Noul Co., Ltd. a Korea-based medical AI company, announced that it presen...
SINEXCEL Recognized as a Tier 1 Low-Voltage Power Quality Supplier
SHENZHEN, China, March 20, 2025 /PRNewswire/ -- SINEXCEL (300693.SZ), a global pioneer in power quality, energy storage and EV charging solutions, has been recognized by Wintelligence, a leading industrial research and consulting firm, as a Tier 1 Low-Voltage Power Quality Supplier inChina. This ...
Seegene Unveils HPV Genotyping Solution at EUROGIN 2025
- Presented a roadmap to enhance screening reliability at the world's leading multidisciplinary HPV congress held inPortugal from March 16-19 - Demonstrated how self-collected samples for HPV testing can bridge gaps in cervical cancer screening and advance HPV screening goals SEOUL, South K...
Cheche Group Schedules Fourth Quarter and Full Year 2024 Earnings Release and Conference Call Date
BEIJING, March 20, 2025 /PRNewswire/ -- Cheche Group Inc.
TiumBio's Partner Hansoh Pharma Expands Indications for Merigolix (HS-10518) with Initiation of ART (Assisted Reproductive Technology) Development
* Clinical Trial Approval of merigolix (TU2670, HS-10518) for the inhibition of premature LH (luteinizing hormone) surges in women undergoing COS (controlled ovarian stimulation) inChina SEONGNAM, South Korea, March 20, 2025 /PRNewswire/ -- TiumBio (KOSDAQ: 321550), a clinical-stage biopharmace...
Canadian Solar's e-STORAGE to Deliver 576 MWh DC of Energy Storage Systems for Strata Clean Energy's White Tank Battery Project in Arizona
KITCHENER, ON, March 20, 2025 /PRNewswire/ -- Canadian Solar Inc
Zeekr Group Files Its 2024 Annual Report on Form 20-F
HANGZHOU, China, March 20, 2025 /PRNewswire/ -- ZEEKR Intelligent Technology Holding Limited ("Zeekr Group" or the "Company") (NYSE: ZK), the world's leading premium new energy vehicle group, today announced that it filed its 2024 annual report on Form 20-F for the fiscal year endedDecember 31, 2...
HUYA Inc. Announces Ex-dividend Date for Recently Announced Cash Dividend
GUANGZHOU, China, March 20, 2025 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game live streaming platform inChina, today announced that the New York Stock Exchange ("NYSE") has setJuly 1, 2025 as the ex-dividend date for the Company's cash dividend to be paid in 20...
Yiren Digital Reports Fourth Quarter and Fiscal Year 2024 Financial Results
BEIJING, March 20, 2025 /PRNewswire/ -- Yiren Digital Ltd. (NYSE: YRD) ("Yiren Digital" or the "Company"), an AI-powered platform providing a comprehensive suite of financial and lifestyle services inChina, today announced its unaudited financial results for the quarter endedDecember 31, 2024. F...
Dizal's Golidocitinib in Combination with Anti-PD-1 Shows Promise in IO Resistant Non-Small Cell Lung Cancer
* Golidocitinib is a JAK1 only inhibitor approved for the treatment of relapsed or refractory PTCL * The combination of golidocitinib and PD-1 antibody showed synergistic anti-tumor effects in anti-PD-1-resistant NSCLC SHANGHAI, March 20, 2025 /PRNewswire/ -- Dizal (SSE: 688192), a biopharmac...
Baozun Announces Fourth Quarter and Fiscal Year 2024 Unaudited Financial Results
SHANGHAI, March 20, 2025 /PRNewswire/ -- Baozun Inc. (Nasdaq: BZUN and HKEX: 9991) ("Baozun", the "Company" or the "Group"), a leading brand e-commerce solution provider and digital commerce enabler inChina, today announced its unaudited financial results for the fourth quarter and fiscal year en...
Qudian Inc. Reports Fourth Quarter and Full Year 2024 Unaudited Financial Results
XIAMEN, China, March 20, 2025 /PRNewswire/ -- Qudian Inc. ("Qudian" or "the Company" or "We") (NYSE: QD), a consumer-oriented technology company inChina, today announced its unaudited financial results for the quarter and full year endedDecember 31, 2024. Fourth Quarter 2024 Financial Highlights...
111, Inc. Announces Fourth Quarter and Fiscal Year 2024 Financial Results
* Achieved First-Ever Annual Operating Profit * Bottom Line Improved by RMB332.7 Million YoY in 2024 * Operating Expenses as a Percentage of Revenues Decreased 230 Basis Points YoY in 2024 * Q4'24 Operating Expenses as a Percentage of Revenues Decreased 470 Basis Points YoY * Achieved Fi...
Week's Top Stories
Most Reposted
InfoComm Asia 2026 - Asia's Super Connector for Professional AV - Takes Place Next Week in Bangkok
[Picked up by 297 media titles]
2026-07-07 09:00A New Chapter Beckons: Four Seasons Resorts of Asia Celebrates Parenthood with Babymoon Offerings
[Picked up by 291 media titles]
2026-07-10 13:30PropertyGuru Group's 2025 Sustainability Report Reinforces its Commitment to More Resilient and Inclusive Urban Futures Across Southeast Asia
[Picked up by 291 media titles]
2026-07-08 12:09NCS launches enterprise AI platforms and products; deepens partnerships to accelerate AI-driven business transformation
[Picked up by 286 media titles]
2026-07-09 08:00Gene Solutions' SPOT-MAS 10 Places Asia-Led Cancer Screening Innovation in the Global Spotlight
[Picked up by 285 media titles]
2026-07-07 06:00